Genius Sports sold off after Legend acquisition dilution and one-off EPS charges. But 28% EBITDA growth guidance creates a binary test at Q2 earnings in August.
Alpha Score of 26 reflects poor overall profile with weak momentum, poor value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Genius Sports Ltd (NYSE:GENI) has taken a beating this year. The stock sold off after the Legend acquisition diluted equity and produced one-off charges to EPS. The question now is whether the selloff overshot the damage.
The company is guiding for 28% year-over-year EBITDA growth. That number is the crux of the debate. Bears see the dilution and the charges and assume the narrative is broken. Bulls look at the growth rate and see a buying opportunity.
The Legend deal closed in early 2025. Genius issued shares to fund the purchase, which hit per-share metrics. The one-off charges – integration costs, restructuring, accounting adjustments – are non-recurring by definition. The EBITDA forecast implies the core business is compounding faster than the dilution rate.
Genius runs the data and betting feed for most major sports leagues. Its contracts with the NFL, NBA, and English Premier League are long-term and exclusive. Revenue tracks the expansion of legal sports betting, which is still rolling out state by state in the U.S. and gaining traction in new international markets. The company also sells AI-driven analytics to leagues and broadcasters. Those contracts have long tails and high renewal rates.
The stock now trades at a lower enterprise value-to-EBITDA multiple than before the deal. If Genius hits the 28% growth target, the multiple compression looks unwarranted. If it misses, the stock faces another leg down.
The next catalyst is the Q2 earnings report, due in August. The numbers to watch are EBITDA margins and whether management raises or maintains full-year guidance. A beat with an upward revision would validate the bull case. A miss would confirm the bear thesis.
The selloff has created a lower entry point. The risk is real. This stock is not for passive holders; it is for traders who can watch the earnings date and decide before the print. The GENI stock page is available for those tracking the name.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.